Your browser doesn't support javascript.
Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.
König, Marton; Torgauten, Hilde Marie; Tran, The Trung; Holmøy, Trygve; Vaage, John Torgils; Lund-Johansen, Fridtjof; Nygaard, Gro Owren.
  • König M; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Torgauten HM; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Tran TT; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Holmøy T; Department of Neurology, Akershus University Hospital, Oslo, Norway.
  • Vaage JT; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Lund-Johansen F; Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Nygaard GO; Department of Neurology, Oslo University Hospital, Oslo, Norway.
JAMA Neurol ; 79(3): 307-309, 2022 03 01.
Article in English | MEDLINE | ID: covidwho-1649498
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Topics: Vaccines Limits: Humans Language: English Journal: JAMA Neurol Year: 2022 Document Type: Article Affiliation country: Jamaneurol.2021.5109

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Topics: Vaccines Limits: Humans Language: English Journal: JAMA Neurol Year: 2022 Document Type: Article Affiliation country: Jamaneurol.2021.5109